263 related articles for article (PubMed ID: 30683261)
21. Chemotherapy, Biologic, and Immunotherapy Breakthroughs in Cancer Care.
Rojas C; Casablanca Y
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):137-154. PubMed ID: 30683260
[TBL] [Abstract][Full Text] [Related]
22. Biologic directed therapies in gynecologic oncology.
Farley JH; Birrer MJ
Curr Oncol Rep; 2003 Nov; 5(6):459-67. PubMed ID: 14521804
[TBL] [Abstract][Full Text] [Related]
23. Management of Gynecologic Cancers In Relation to Genetic Predisposition.
Lahiri Batra S
Semin Oncol Nurs; 2019 Apr; 35(2):182-191. PubMed ID: 30871842
[TBL] [Abstract][Full Text] [Related]
24. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
25. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
[TBL] [Abstract][Full Text] [Related]
26. [New directions in biomarker research, drug development and personalized medicine].
Németh G; Jelinek I
Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
[TBL] [Abstract][Full Text] [Related]
27. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
Akkad J; Bochum S; Martens UM
Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
[TBL] [Abstract][Full Text] [Related]
28. Advances in the recognition and management of hereditary cancer.
Kulkarni A; Carley H
Br Med Bull; 2016 Dec; 120(1):123-138. PubMed ID: 27941041
[TBL] [Abstract][Full Text] [Related]
29. Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.
Collymore DC; Kobilis SL; Lundquist TG; McGivney WT; Pezalla EJ; Poage W
Am J Manag Care; 2016 Feb; 22(2 Suppl):s20-5. PubMed ID: 26978033
[TBL] [Abstract][Full Text] [Related]
30. Artificial intelligence-based risk stratification, accurate diagnosis and treatment prediction in gynecologic oncology.
Jiang Y; Wang C; Zhou S
Semin Cancer Biol; 2023 Nov; 96():82-99. PubMed ID: 37783319
[TBL] [Abstract][Full Text] [Related]
31. [Treat to target and personalized medicine (precision medicine)].
Detert J; Burmester GR
Z Rheumatol; 2016 Aug; 75(6):624-32. PubMed ID: 27365026
[No Abstract] [Full Text] [Related]
32. Germline and Somatic Tumor Testing in Gynecologic Cancer Care.
Alldredge J; Randall L
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):37-53. PubMed ID: 30683265
[TBL] [Abstract][Full Text] [Related]
33. Update on Genetic Testing in Gynecologic Cancer.
Domchek SM; Robson ME
J Clin Oncol; 2019 Sep; 37(27):2501-2509. PubMed ID: 31403865
[No Abstract] [Full Text] [Related]
34. Cell-based immunotherapy in gynecologic malignancies.
Schaar B; Krishnan V; Tallapragada S; Dorigo O
Curr Opin Obstet Gynecol; 2018 Feb; 30(1):23-30. PubMed ID: 29227304
[TBL] [Abstract][Full Text] [Related]
35. Initiation of a formalized precision medicine program in gynecologic oncology.
Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
[TBL] [Abstract][Full Text] [Related]
36. Immuno-Oncology in the Era of Personalized Medicine.
Gwin WR; Disis ML; Ruiz-Garcia E
Adv Exp Med Biol; 2019; 1168():117-129. PubMed ID: 31713168
[TBL] [Abstract][Full Text] [Related]
37. [Translational research - towards personalized medicine].
Tokui T
Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):122-5. PubMed ID: 23470475
[No Abstract] [Full Text] [Related]
38. Gynecologic oncology: progress not withstanding.
Grendys EC
Curr Opin Obstet Gynecol; 1998 Feb; 10(1):1-2. PubMed ID: 9484621
[TBL] [Abstract][Full Text] [Related]
39. Society of Gynecologic Oncology 2016 Annual Meeting: Highlights and context.
Moore K; Stone R; Walter A
Gynecol Oncol; 2016 Jun; 141(3):416-420. PubMed ID: 27138457
[No Abstract] [Full Text] [Related]
40. Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.
Reyes HD; Thiel KW; Carlson MJ; Meng X; Yang S; Stephan JM; Leslie KK
Mol Diagn Ther; 2014 Apr; 18(2):137-51. PubMed ID: 24403167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
